Bavarian Nordic A/S
Bavarian Nordic A/S
10/29/2025 | Press release | Distributed by Public on 10/29/2025 06:29
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
Published: 2025-10-29 13:29:01 CET Bavarian Nordic A/S - Major shareholder announcements
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
COPENHAGEN, Denmark, October 29, 2025 - Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025.
About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit https://www.bavarian-nordic.com.
Contact investors:Europe: Disa Tuominen, IR Manager, [email protected]: Graham Morrell, Gilmartin Group, [email protected], Tel: +1 781 686 9600
Contact media:Nicole Seroff, Vice President Corporate Communications, [email protected], Tel: +45 53 88 06 03
Company Announcement no. 34 / 2025
Attachment
- 2025-34-en
2025-34-en.pdf https://attachment.news.eu.nasdaq.com/a9eaaff1152100496c482d72d7472e46a
Company News Subscribe European Market Activity Nasdaq Europe
© 2025, Nasdaq, Inc. All Rights Reserved.
Bavarian Nordic A/S published this content on October 29, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2025 at 12:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]